0003-0371Level 3
NULOJIX (BELATACEPT)
**Product type:** Human Prescription Drug
**Active ingredient:** BELATACEPT
**Strength:** 250 mg/1
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** E.R. Squibb & Sons, L.L.C.
**Marketing category:** BLA (BLA125288)
**Pharmacologic class:** CD80-directed Antibody Interactions [MoA], CD86-directed Antibody Interactions [MoA], Selective T Cell Costimulation Blocker [EPC], T Lymphocyte Costimulation Activity Blockade [PE]
GET
/api/v1/systems/ndc_fda/nodes/0003-0371Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.